Innovation and imitation,opportunity aπ>≠nd challenge
Asia-Pacific Pharma IP ♠φLeader summit2019---14th-15th ✘±¥™NOV, Beijing CHINAOn March 19, 2019, the World±→≥ Intellectual Property Organization (WIPO) p£ublished its global intelα lectual property report 2018.A£σ±™sian innovators filed more than half of the₩πir international patent applications through WIP✔♠"☆O for the first time in 2018, with significa '₹φnt growth in China, India and So₹₹σuth Korea, the report noted. As a teδ$£chnology-intensive industry, pha∏✔rmaceutical industry attaches great importance to÷$∑♠ patent application and intellectu≠✘↓al property protection.In recent years, the si±≈ φze of the global pharmaceutical market≥≥☆× has maintained a ste δady growth, with China, South Korea, In∏$Ωdia and other emerging markets♠π presenting a rapid growth momentu≤×¥✔m. Due to the different intellectual properγ♣∞ty policies of diffe"≤rent countries, the strategic layout of glo"€bal intellectual prope₽<$rty, the differences of p"✘∑πharmaceutical intellectual property≈↕λ♣ policies of Asia-pacif•↓♣ic countries, the patent review process, litigat€↕ion procedures and Generic drug patent str±'∞ategy have gradually become the hot spotΩ✔s of the pharmaceutical intΩ ellectual property industryσ'☆.In this context, the 2019 Asia-pacific Pharmacε≈∏eutical IP Leader Summit wil↔δ✔l be held in Beijing on November 14-15, ←™and will attract more than 500 industry ±×→experts from domestic and foreign pharmaceut™ ical companies, biotechnology companies, govern±γ©ments, associations, law firms, intellectual pr↔σoperty agents and other companies to attend.Ag₹✘enda Framework:Section 1:Interpretation of Poliπ¶cy: Development of Pharmaceutical I♠±•δP under the New Legislative Landscape S•∏σ"ection 2:Pharmaceutical R&★πamp;D Innovation and IP ProΩ§∞÷tection -- Global VisionSection 3:Case Sha Ω ring of Pharmaceutical Patent Invalidπα•↓ity, Infringement, LitigationSect§ ion 4:Opportunities and challenges for gene✘λπ☆rics companies under the new ←→→situation HOTSPOT:↓'₩ü Medical Policy Interpretation u"®¥nder the Background of Pat≤"ent Law Amendmentü ✔↑₽The innovation of Judicial Mechanism Promoδ→שtes the Development of Pharmaceutical Intellectuγ≥×al Propertyü Intelle →×ctual Property Management↑λ Experience in Multinational Pharmaceutical Compa >φ∞nies, Patent Layout Strategy, Liβ↑∞tigation Strategyü he Data ✔↓₹Protection Regulations of Drug Test—New Eraü&nbs♥±p; Trade Secrets and Patent L≥↓™↑ayout in the Medical F→♦ ieldü Establishing The Internal Intelle✘δβctual Property System under The New Legisla↔←↑®tive Landscapeü Opportunities and Challenge≤₩s of Pharmaceutical Enterprise' ♠↓s under Patent Term Compensati♦↕₹βon System--- Global Vision and Its Implications÷® for Chinaü Latest Changes in Eu ✔ropean Patent Application and Review Proced✘↓¶uresü Analysis of Hot C↔δ∑↑ases of Recent Patent Invalidationü&nbγ♠sp; The Procedure of American Pharma∏≠γceutical Patent litigation and its Enlightenmen¥"t to Chinese Pharmaceutical Enterprises &nbs™≥≠p;ü Application techniques and pr↑→₹'otection strategies for European↑¥ and American biomedical patentsü&n ™bsp; Changes in standards for creative rev↕←iew of patentsü European, Ame✔>←rican and Japanese Medical Pate'φnt Examination Cases and its €♥implications for DomesticPharmaceutical C☆ompaniesü Recent Hot Patent Infringeme→¥✔™nt Cases Analysisü The Strategy of ♥βIndian Generic Drug Companies in R&D←♣γ and Pre-PAü How to avoid the Pa←← tent Trap in Generic Drug Development ©ü The Strategy of Generic Drug Companies t£πo Enter the European and American Marketsü&nbs ☆™'p; Patentability in Europe,±¶₩ the United States and Chinaü&$₩★nbsp; Patent litigation in Europeü > Doubts around the Unif↔€ied Patent Court (UPC) agreement and <>↑<Brexitü Second medical use patentsCo✔¶φmposition of participants: Sum↕φ ≠mit highlights:10+ Hot topic20+ Authoritat× ✘ive speech5 0+ Industry media4 0+ BIC110+phar★$ma company 500+專業(yè)參會(™βγhuì)嘉賓 &nbs¥₩> p; ₽"≠ &nb↔ <sp; δ™→ Professional participan✘δ§$tsOfficial registration and consultatio'δשn channels:Contact:AnnPhone: 021-€±•65650305Email:Marketing@zenseegroup.comhttp://en>™.zenseegroup.com/p/510934/